Mary Catchpole
Mary Catchpole, a 19-year-old from Norfolk, has become the first patient in Europe to receive a newly licensed treatment for Activated PI3-kinase Delta Syndrome (APDS), a rare inherited disorder that severely affects the immune system. Having lost several family members to this life-threatening condition, Mary expresses hope and joy with the new treatment, which she believes will allow her to live a fuller life.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Mary Catchpole is the first person to benefit from a new treatment for a rare condition affecting her family.
9